In a report released today, Joseph Catanzaro from Piper Sandler maintained a Hold rating on Iovance Biotherapeutics (IOVA – Research Report), ...

Piper Sandler analyst Joseph Catanzaro lowered the firm’s price target on Iovance Biotherapeutics (IOVA) to $7.50 from $10 and keeps a Neutral ...

Iovance Biotherapeutics Inc (IOVA) stock saw a decline, ending the day at $6.19 which represents a decrease of $-0.06 or -0.96% from the prior close of $6.25. The stock opened at $6.28 and touched a ...

It was about a year ago that shares of Iovance Biotherapeutics (NASDAQ: IOVA) began to take off. Could this be a great buying ...

Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $6.25 which represents a slight increase of $0.06 or 0.97% from the prior close of $6.19. The stock opened at $6.24 and ...

Iovance Biotherapeutics (NASDAQ: IOVA), a small-cap biotech company, has an innovative approach to treating cancer that ...

Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...

If you're looking for an under-the-radar stock that could deliver enormous gains in a defined time frame, the ...

One company Wall Street analysts have set their sights on, Iovance Biotherapeutics (NASDAQ: IOVA), is pioneering a new approach to treating cancer. Outstanding clinical trial results pushed this ...

Stifel maintains Buy on Iovance stock with $21 target On Monday, Stifel analysts maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a steady price target of $21.00. According to ...

After hours: 7:59:05 p.m. EST ...